TY - JOUR
TI - Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2019
ET - 2019/04/24
VL - 42
IS - 3
SP - 108
EP - 109
DO - 10.18773/austprescr.2019.033
LA - eng
UR - https://australianprescriber.tg.org.au/articles/sofosbuvir-velpatasvir-voxilaprevir-for-hepatitis-c.html
KW - Vosevi
KW - sofosbuvir
KW - velpatasvir
KW - voxilaprevir
KW - hepatitis C
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -